Lipid profile in neuromyelitis optica spectrum disorder between clinical attack and remission state. (P6.394)
Misong Choi(Samsung Medical Center), Ju‐Hong Min(Samsung (South Korea)), Byoung Joon Kim(Samsung Medical Center), Jin Myoung Seok(Samsung Medical Center), Hee Young Shin(Seoul National University Children's Hospital), Kwang Ho Lee(Chonnam National University)
Cited by 0
Related Papers
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
|Multiple Sclerosis Journal|2013|84
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea
|Multiple Sclerosis Journal|2017|82
Oral Solubilized Ursodeoxycholic Acid Therapy in Amyotrophic Lateral Sclerosis: A Randomized Cross-Over Trial
|Journal of Korean Medical Science|2012|58